Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyratech Regulatory News (TYR)

  • There is currently no data for TYR

Arysta milestone payment

10 Jan 2008 07:00

TyraTech, Inc.10 January 2008 Press Release 10 January 2008 TyraTech, Inc. ("TyraTech" or "the Company") TyraTech achieves insecticide development and financial milestones with partner Arysta LifeScience TyraTech Inc. (AIM: TYR), the pioneer of safer, effective and natural pesticideproducts, today announces it has achieved development and financial milestonesfrom Arysta LifeScience Corporation ("Arysta"), as part of its 2006 exclusiveglobal licensing and co-development agreement to manufacture and market a numberof insecticide products for certain horticultural markets. TyraTech is developing proprietary compounds that target receptors found oninsects and other invertebrates, but are not found on humans or animals. Thesecompounds - called TyraTech Naturals - are derived from plants and can killinsects with the potency of chemical pesticides, but without their toxicity.The partnership with Arysta is to develop new products based on the TyraTechcompounds for the control of insects in certain horticultural markets. Thepartnership has different progressive development stages, which when they aresuccessfully reached, result in milestone payments to TyraTech. The two milestone payments above relate to achieving specific insecticideefficacy and cost targets for TyraTech Natural products in two of the licensedapplications. Field testing for the lead product prototypes has been underwaysince late 2006, when an exclusivity payment was received. Douglas Armstrong PhD, Chief Executive Officer of TyraTech said: "The globalhorticultural insecticide market includes fruits and vegetables as well asprofessional turf areas such as golf courses, where safer, more responsibleinsecticides are increasingly demanded by both the consumer as well as theregulatory agencies. TyraTech's technology is designed to meet this opportunitywith active insecticides that have a strong combination of potency and safety,as well as providing a new solution to the increasing problem of insectresistance to traditional insecticides. With our partner Arysta, we can notonly accelerate the development of products, but also have an experienced salesand marketing capability to bring these products into the commercialmarketplace." TyraTech is actively developing products for other markets that require safe andeffective control of insects and invertebrate pathogens. In October TyraTechannounced the release of its first TyraTech Naturals insecticide product, ageneral-use crawling insect spray for sale to businesses - particularly thehospitality industry - for direct insect control in inhabited spaces. Enabledby the safety profile of TyraTech Naturals, the Company is also working in closealliance with Kraft Foods to develop a line of functional food products intendedfor the prevention or control of intestinal parasites. The successfulachievement of a major development milestone in this partnership was alsorecently announced by TyraTech. Dr. Armstrong continued: "We are committed to establishing a new standard forcommercial insecticides based on the unique level of combined potency and safetyof TyraTech Naturals. Our recent progress is an exciting start for all involvedfrom our hard working staff, our partners, our new customers, and particularlyfor our shareholders." - Ends - For further information:TyraTech Inc.Douglas Armstrong PhD, Chief Executive Officer Tel: +1 (321) 409 7403 www.tyratech.comNomura Code SecuritiesCharles Walker / Clare Terlouw Tel: +44 (0) 20 7776 1200 www.nomuracode.com Media enquiries:AbchurchHeather Salmond / Justin Heath Tel: +44 (0) 20 7398 7700justin.heath@abchurch-group.comGareth Meadgareth.mead@abchurch-group.com www.abchurch-group.com About TyraTech, Inc. TyraTech is pioneering a new safer class of highly effective, pesticides andanti-parasitic compounds to address global agriculture, horticulture, functionalfoods, healthcare and veterinary markets. Using a revolutionary chemoreceptorscreening process, TyraTech has identified proprietary blends of natural oilsthat stimulate the reactions and biological behaviour of insects and parasitesso that they can be effectively repelled or killed. TyraTech's technologyprevents the development of resistance and avoids the environmental concerns andhuman health risks of chemical solutions whilst still being at least, if notmore, effective. The Company's products have been validated through strong partnerships withmultinational conglomerates operating within a growing US$23 billion worldwidemarket that is being increasingly driven by environmental legislation andend-user demand. TyraTech continues to develop new product applications based on safe, naturalingredients with a broad range of partners around the world. www.tyratech.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
8th Nov 20185:25 pmRNSTyratech
2nd Nov 20185:30 pmRNSTyratech
31st Oct 20183:01 pmRNSResult of Special Meeting, Cancellation from AIM
25th Oct 20187:00 amRNSSpecial Meeting and Acquisition Update
18th Oct 20183:00 pmRNSNominee accounts
9th Oct 20182:23 pmRNSPosting of Proxy Statement and Timetable Update
5th Oct 201810:05 amRNSUpdate
28th Sep 20188:50 amRNSInterim Results
28th Sep 20187:00 amRNSConditional Merger Agreement Signed with AMVAC
23rd May 20187:00 amRNSFinal Results
9th May 20187:00 amRNSProgress in 2018 on products and milestones
3rd May 20187:00 amRNSChange of Adviser
24th Jan 20185:44 pmRNSHolding(s) in Company
18th Jan 20187:00 amRNSHolding(s) in Company
15th Jan 20187:00 amRNSResult of Tender Offer
11th Jan 20181:08 pmRNSTR-1
9th Jan 20185:01 pmRNSTR-1
5th Jan 20187:00 amRNSResult of Tender Offer
28th Dec 20177:00 amRNSResult of Special Meeting
4th Dec 20177:00 amRNSTender Offer to Shareholders and Notice of Meeting
12th Sep 20177:00 amRNSInterim Results for Six Months Ended 30 June 2017
24th Aug 20177:00 amRNSCOMPANY UPDATE AND DATE OF INTERIM RESULTS
4th Jul 20172:29 pmRNSJoint Development and License Agreement
29th Jun 20177:00 amRNSResult of AGM
7th Jun 20177:00 amRNSTYR TR-1: Notification of major interest in shares
9th May 20177:00 amRNSResults for the Year Ended 31 December 2016
28th Apr 20173:24 pmRNSFurther re Notice of Final Results
22nd Mar 20178:57 amRNSTR-1: Notification of major interest in shares
9th Feb 20177:00 amRNSPre-close Trading Update
19th Sep 20163:59 pmRNSDirector/PDMR Shareholding
15th Sep 20161:18 pmRNSDirectors' Dealings
13th Sep 20167:00 amRNSInterim Results for Six Months Ended 30 June 2016
28th Jul 20167:00 amRNSPre Close Trading Update
8th Jun 20163:22 pmRNSResult of AGM and Board Change
22nd Apr 20161:57 pmRNSDirectors' Dealings
15th Apr 201612:03 pmRNSAward of Share Options
15th Apr 201611:57 amRNSDirectors' Dealings
14th Apr 20167:00 amRNSDirectors' Dealings
11th Apr 20167:00 amRNSAppointment of José Barella as Chairman
4th Apr 20167:00 amRNSNotice of Preliminary Results
3rd Feb 201612:31 pmRNSHolding(s) in Company
1st Feb 20161:08 pmRNSDirector's Dealings
1st Feb 20167:00 amRNSPre-close Trading Update
20th Jan 20167:00 amRNSAppointment of Erica H. Boisvert as CFO
13th Jan 20167:00 amRNSNew Product Range Launch & Distribution Agreement
17th Dec 20154:01 pmRNSTR-1: Notification of Major Interest in Shares
4th Dec 201511:00 amRNSTR-1: Notification of major interest in shares
26th Nov 201512:51 pmRNSTR-1: Notification of Major Interest in Shares
16th Nov 20155:01 pmRNSResult of Special Meeting & Director Shareholdings
4th Nov 20157:00 amRNSPlacing and Subscription to raise £3.16m

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.